STUDIES ON THE SITE OF ACTION OF THE ARYLSULFONYLUREAS IN MAN. II.
A. Renold,D. Martin,B. Boshell,G. W. Thorn
DOI: https://doi.org/10.1111/j.1749-6632.1957.tb54577.x
IF: 6.499
1957-07-01
Annals of the New York Academy of Sciences
Abstract:Previous studies from this laboratory have been concerned with the characterization of arylsulfonylurea-induced hypoglycemia as due primarily either to increased peripheral glucose utilization or to decreased hepatic glucose synthesis or re1ease.l I t was observed that the hyperglycemia that follows the intravenous administration of fructose and galactose loads to patients with diabetes mellitus was considerably decreased by the previous administration of carbutamide or tolbutamide, although glucose tolerance remained unchanged. Since the liver is principally responsible for the conversion of fructose and galactose to glucose, this observation was interpreted as suggesting an effect of the hypoglycemic sulfonylureas upon hepatic glucose synthesis or release. This interpretation is in accord with the findings of others in isolated tissues,2in experimental anirnal~,~. and in man.6. 7* 8, It is appreciated that these studies in no way excluded other sites of action of these compounds. In these earlier studies an effect of the hypoglycemic sulfonylureas upon peripheral glucose utilization in man was sought, but not found.' Since an important hypothesis concerning the mode of action of these compounds is that of increased insulin synthesis or release,lO* l1 a physiological event that should lead to increased peripheral glucose utilization, re-evaluation of some metabolic indices frequently associated with increased peripheral glucose utilization has been undertaken. In addition, an attempt has been made to demonstrate the postulated increased insulin secretion by measuring insulinlike activity in plasma before and after intravenous administration of the compound Material artd Methods